Estimated cumulative LDL-C exposure and risk of recurrent cardiovascular events after acute coronary syndrome.
BACKGROUND AND AIMS Lipid-lowering therapy is essential for secondary prevention in patients with acute coronary syndrome (ACS). Although cumulative LDL-C exposure is a major determinant of cardiovascular risk, its assessment is often impractical due to the lack of longitudinal lipid data. Estimated cumulative LDL-C ex...